3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
10
Breast Neoplasms
7
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Melanoma
3
Hematologic Neoplasms
3
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Malignant Solid Neoplasm
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Vaping
1
Urologic Neoplasms
1
Urologic Diseases
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Speech
1
Smoking
1
Seroma
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Interventions
pembrolizumab
2
Cisplatin
2
trastuzumab deruxtecan
1
liposomal doxorubicin
1
lenvatinib
1
dostarlimab
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Gemcitabine
1
Doxorubicin
1
CTLA-4 Antigen
1
Bupropion
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Standard of Care
×
30 days
×
Clear all
No trials found.